[1] |
Rozengurt E. Protein kinase D signaling: multiple biological functions in health and disease[J]. Physiology (Bethesda), 2011, 26(1): 23⁃33. DOI: 10.1152/physiol.00037.2010.
|
[2] |
Ellwanger K, Hausser A. Physiological functions of protein kinase D in vivo[J]. IUBMB Life, 2013, 65(2): 98⁃107. DOI: 10.1002/iub.1116.
|
[3] |
Tandon M, Salamoun JM, Carder EJ, et al. SD⁃208, a novel protein kinase D inhibitor, blocks prostate cancer cell proliferation and tumor growth in vivo by inducing G2/M cell cycle arrest[J]. PLoS One, 2015, 10(3): e0119346. DOI: 10.1371/journal.pone.0119346.
|
[4] |
Sundram V, Chauhan SC, Jaggi M. Emerging roles of protein kinase D1 in cancer[J]. Mol Cancer Res, 2011, 9(8): 985⁃996. DOI: 10.1158/1541⁃7786.MCR⁃10⁃0365.
|
[5] |
Karam M, Legay C, Auclair C, et al. Protein kinase D1 stimulates proliferation and enhances tumorigenesis of MCF⁃7 human breast cancer cells through a MEK/ERK⁃dependent signaling pathway[J]. Exp Cell Res, 2012, 318(5): 558⁃569. DOI: 10.1016/j.yexcr.2012.01.001.
|
[6] |
Liou GY, Storz P. Protein kinase D enzymes: novel kinase targets in pancreatic cancer[J]. Expert Rev Gastroenterol Hepatol, 2015, 9(9): 1143⁃1146. DOI: 10.1586/17474124.2015.1069706.
|
[7] |
Jensen DD, Zhao P, Jimenez⁃Vargas NN, et al. Protein kinase D and Gβγ subunits mediate agonist⁃evoked translocation of protease⁃activated receptor⁃2 from the golgi apparatus to the plasma membrane[J]. J Biol Chem, 2016, 291(21): 11285⁃11299. DOI: 10.1074/jbc.M115.710681.
|
[8] |
Arun SN, Kaddour⁃Djebbar I, Shapiro BA, et al. Ultraviolet B irradiation and activation of protein kinase D in primary mouse epidermal keratinocytes[J]. Oncogene, 2011, 30(13): 1586⁃1596. DOI: 10.1038/onc.2010.540.
|
[9] |
Zugaza JL, Waldron RT, Sinnett⁃Smith J, et al. Bombesin, vasopressin, endothelin, bradykinin, and platelet⁃derived growth factor rapidly activate protein kinase D through a protein kinase C⁃dependent signal transduction pathway[J]. J Biol Chem, 1997, 272(38): 23952⁃23960. DOI: 10.1074/jbc.272.38.23952.
|
[10] |
Bollag WB, Dodd ME, Shapiro BA. Protein kinase D and keratinocyte proliferation[J]. Drug News Perspect, 2004, 17(2): 117⁃126. DOI: 10.1358/dnp.2004.17.2.829045.
|
[11] |
Choudhary V, Olala LO, Kaddour⁃Djebbar I, et al. Protein kinase D1 deficiency promotes differentiation in epidermal keratinocytes[J]. J Dermatol Sci, 2014, 76(3): 186⁃195. DOI: 10.1016/j.jdermsci.2014.09.007.
|
[12] |
Rashel M, Alston N, Ghazizadeh S. Protein kinase D1 has a key role in wound healing and skin carcinogenesis[J]. J Invest Dermatol, 2014, 134(4): 902⁃909. DOI: 10.1038/jid.2013.474.
|
[13] |
Chiou YS, Sang S, Cheng KH, et al. Peracetylated (⁃)⁃epigallocatechin⁃3⁃gallate (AcEGCG) potently prevents skin carcinogenesis by suppressing the PKD1⁃dependent signaling pathway in CD34+ skin stem cells and skin tumors[J]. Carcinogenesis, 2013, 34(6): 1315⁃1322. DOI: 10.1093/carcin/bgt042.
|
[14] |
Kempkes C, Rattenholl A, Buddenkotte J, et al. Proteinase⁃activated receptors 1 and 2 regulate invasive behavior of human melanoma cells via activation of protein kinase D1[J]. J Invest Dermatol, 2012, 132(2): 375⁃384. DOI: 10.1038/jid.2011.314.
|
[15] |
Ristich VL, Bowman PH, Dodd ME, et al. Protein kinase D distribution in normal human epidermis, basal cell carcinoma and psoriasis[J]. Br J Dermatol, 2006, 154(4): 586⁃593. DOI: 10. 1111/j.1365⁃2133.2005.07073.x.
|
[16] |
Rybin VO, Guo J, Steinberg SF. Protein kinase D1 autophosphory⁃lation via distinct mechanisms at Ser744/Ser748 and Ser916[J]. J Biol Chem, 2009, 284(4): 2332⁃2343. DOI: 10.1074/jbc.M806381200.
|